Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Shirley R. Kuhlmann net worth and biography

Shirley Kuhlmann Biography and Net Worth

EVP of Collegium Pharmaceutical

Shirley R. Kuhlmann serves as Executive Vice President, General Counsel, Secretary of the Company. Ms. Kuhlmann has served as our Executive Vice President and General Counsel since March 2018. Prior to joining us, Ms. Kuhlmann was a corporate and securities attorney at Pepper Hamilton LLP from September 2007 until March 2018. At Pepper Hamilton, where she was made a partner effective January 2017, Ms. Kuhlmann advised private and public companies on a range of commercial and transactional matters, including financings, corporate governance and disclosure matters, and mergers and acquisitions and other business combination transactions. Ms. Kuhlmann holds a B.A. in Economics/Political Science from Columbia University in 2004 and a J.D. from Emory University School of Law in 2007.

What is Shirley R. Kuhlmann's net worth?: The estimated net worth of Shirley R. Kuhlmann is at least $3.60 million as of September 5th, 2024. Ms. Kuhlmann owns 120,161 shares of Collegium Pharmaceutical stock worth more than $3,600,024 as of November 23rd. This net worth evaluation does not reflect any other assets that Ms. Kuhlmann may own. Additionally, Ms. Kuhlmann receives a salary of $842,900.00 as EVP at Collegium Pharmaceutical. Learn More about Shirley R. Kuhlmann's net worth.
How old is Shirley R. Kuhlmann?: Ms. Kuhlmann is currently 40 years old. There are 5 older executives and no younger executives at Collegium Pharmaceutical. The oldest executive at Collegium Pharmaceutical is Dr. Thomas B. Smith FAAFP, M.D., Executive VP & Chief Medical Officer, who is 63 years old. Learn More on Shirley R. Kuhlmann's age.
What is Shirley R. Kuhlmann's salary?: As the EVP of Collegium Pharmaceutical, Inc., Ms. Kuhlmann earns $842,900.00 per year. There are 2 executives that earn more than Ms. Kuhlmann. The highest earning executive at Collegium Pharmaceutical is Mr. Joseph J. Ciaffoni, President, CEO & Director, who commands a salary of $1,690,000.00 per year. Learn More on Shirley R. Kuhlmann's salary.
How do I contact Shirley R. Kuhlmann?: The corporate mailing address for Ms. Kuhlmann and other Collegium Pharmaceutical executives is 100 Technology Center Drive, Stoughton MA, 02072. Collegium Pharmaceutical can also be reached via phone at (781) 713-3699 and via email at [email protected]. Learn More on Shirley R. Kuhlmann's contact information.
Has Shirley R. Kuhlmann been buying or selling shares of Collegium Pharmaceutical?: Shirley R. Kuhlmann has not been actively trading shares of Collegium Pharmaceutical during the last quarter. Most recently, Shirley R. Kuhlmann sold 19,248 shares of the business's stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $38.30, for a transaction totalling $737,198.40. Following the completion of the sale, the executive vice president now directly owns 120,161 shares of the company's stock, valued at $4,602,166.30. Learn More on Shirley R. Kuhlmann's trading history.
Who are Collegium Pharmaceutical's active insiders?: Collegium Pharmaceutical's insider roster includes Joseph Ciaffoni (Pres), Scott Dreyer (EVP), Michael Heffernan (Director), Shirley Kuhlmann (EVP), and Colleen Tupper (Exec. VP & CFO ). Learn More on Collegium Pharmaceutical's active insiders.
Are insiders buying or selling shares of Collegium Pharmaceutical?: During the last year, insiders at the specialty pharmaceutical company sold shares 9 times. They sold a total of 202,376 shares worth more than $6,618,056.46. The most recent insider tranaction occured on September, 13th when EVP Thomas B Smith sold 9,593 shares worth more than $351,295.66. Insiders at Collegium Pharmaceutical own 4.0% of the company. Learn More about insider trades at Collegium Pharmaceutical.
Information on this page was last updated on 9/13/2024.

Shirley R. Kuhlmann Insider Trading History at Collegium Pharmaceutical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/5/2024	Sell	19,248	$38.30	$737,198.40	120,161
11/27/2023	Sell	25,600	$25.78	$659,968.00	119,518
6/26/2023	Sell	17,984	$21.72	$390,612.48	119,518
2/13/2023	Sell	21,811	$26.88	$586,279.68	137,502
9/15/2022	Sell	38,589	$18.07	$697,303.23	109,495
8/11/2022	Sell	300	$20.01	$6,003.00	148,084
5/10/2021	Sell	7,000	$22.77	$159,390.00	89,990
1/20/2021	Sell	6,081	$24.45	$148,680.45	102,891
10/15/2020	Sell	7,060	$20.82	$146,989.20	57,531

Shirley R. Kuhlmann Buying and Selling Activity at Collegium Pharmaceutical

Collegium Pharmaceutical Company Overview

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Today's Range

Now: $29.96

$29.80

$30.76

50 Day Range

MA: $35.69

$29.22

$41.86

2 Week Range

Now: $29.96

$25.16

$42.29

Volume

394,164 shs

Average Volume

475,022 shs

Market Capitalization

$966.21 million

P/E Ratio

12.91

Dividend Yield

N/A

Beta

0.95

This company will win the AI race

From Porter & Company | Ad

You must read this new presentation from Porter Stansberry.

Shirley Kuhlmann Biography and Net Worth

What is Shirley R. Kuhlmann's net worth?

How old is Shirley R. Kuhlmann?

What is Shirley R. Kuhlmann's salary?

How do I contact Shirley R. Kuhlmann?

Has Shirley R. Kuhlmann been buying or selling shares of Collegium Pharmaceutical?

Who are Collegium Pharmaceutical's active insiders?

Are insiders buying or selling shares of Collegium Pharmaceutical?